AHCO

Clemens Jason A

Known title: Chief Financial OfficerCIK: 0001820867

Clemens Jason A's purchase track record

How the stock did after each of Clemens Jason A's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
3
of 3 since December 1, 2021
Stock higher 6 months later
33%
3 months: 33%
Median 6-month return
-4.4%
3 months: -17.3%
Beat the S&P 500
67%
median +4.7% vs. index
PurchaseStockAmount3 months6 months
8/10/2023AHCO$10K-51.4%-49.2%
3/2/2022AHCO$25K+15.5%+17.6%
12/1/2021AHCO$26K-17.3%-4.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

AdaptHealth (AHCO) flagged in Yahoo's cautionary stock list. A recent Yahoo article placed AHCO among three stocks that Wall Street should think twice about. The piece suggests investors may need to re‑evaluate expectations for the company. The stock is currently near its long‑term support level of $5.70 and shows a moderate RSI, which aligns with the cautious tone of the article.

this person other insiders at AHCO

Transaction History

AHCO▲ Buy$0
AHCO▲ Buy$0
AHCO▼ Sell$327K
AHCO▲ Buy$0
AHCO▲ Buy$0
AHCO▼ Sell$44K
AHCO▲ Buy$10K
AHCO▼ Sell$77K
AHCO▲ Buy$0
AHCO▼ Sell$10K
AHCO▼ Sell$77K
AHCO▲ Buy$25K
AHCO▲ Buy$0
AHCO▲ Buy$0
AHCO▲ Buy$26K
AHCO▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.